NCT02057029View on ClinicalTrials.gov

Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Breast CancerEarly Stage Estrogen Receptor (ER) Positive Breast Cancer
Interventions
BEHAVIORAL

BCI Assay Results

The nature of the intervention is to utilize the BCI results in the decision making process for ER-positive breast cancer patients and their physicians.

Trial Locations (1)

06511

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02057029 - Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer | Biotech Hunter | Biotech Hunter